C4 Therapeutics Inc
CCCC2.230USD
+0.240+12.06%
Close 07/11, 16:00（ET）Quotes delayed by 15 min
2.230USD+2.230After-hours (ET)
158.31MMarket Cap
LossP/E TTM
C4 Therapeutics Inc
2.230
+0.240+12.06%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-83.71%-33.28M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
17.57%-24.01M
-9.59%-30.71M
14.41%-19.00M
-24.55%-33.13M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.20M
-6.67%-26.60M
-19.18%-25.67M
-27.52%-18.36M
---18.00M
---24.93M
---21.54M
---14.40M
Net income from continuing operations
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
28.16%-15.66M
-13.04%-24.68M
---22.58M
---20.97M
---21.80M
---21.84M
Operating gains losses
1.79%456.00K
11.63%480.00K
-1.12%442.00K
-2.18%448.00K
-17.80%448.00K
-17.47%430.00K
7.71%447.00K
5.29%458.00K
78.69%545.00K
61.30%521.00K
25.76%415.00K
12.11%435.00K
-32.37%305.00K
-11.51%323.00K
-21.43%330.00K
--388.00K
--451.00K
--365.00K
--420.00K
Other non-cash items
300.00%892.00K
-9.04%503.00K
-77.95%260.00K
-93.25%45.00K
-79.33%223.00K
-56.70%553.00K
-31.45%1.18M
-71.03%667.00K
-46.69%1.08M
-12.59%1.28M
60.60%1.72M
162.49%2.30M
235.10%2.02M
226.85%1.46M
105.17%1.07M
--877.00K
--604.00K
--447.00K
--522.00K
Change in working capital
-511.62%-13.82M
118.13%7.42M
33.31%-9.00M
-37.41%5.87M
153.97%3.36M
615.61%3.40M
-220.72%-13.50M
265.40%9.38M
0.37%-6.22M
96.36%-660.00K
-262.13%-4.21M
-195.98%-5.67M
29.56%-6.24M
-212.39%-18.15M
-139.79%-1.16M
---1.92M
---8.86M
---5.81M
--2.92M
-Change in receivables
-173.82%-4.93M
164.06%7.24M
-1837.50%-9.17M
2586.20%12.43M
-290.37%-1.80M
-75433.33%-11.30M
137.84%528.00K
-893.65%-500.00K
-76.04%945.00K
101.72%15.00K
-83.77%222.00K
102.46%63.00K
376.33%3.94M
-153.94%-871.00K
-68.94%1.37M
---2.56M
--828.00K
---343.00K
--4.41M
-Change in prepaid expenses
107.30%341.00K
-102.12%-28.00K
217.92%816.00K
-127.91%-446.00K
-1037.75%-4.67M
671.35%1.32M
54.02%-692.00K
13.09%1.60M
61.17%498.00K
103.42%171.00K
-2567.21%-1.50M
223.84%1.41M
872.50%309.00K
-242.43%-5.00M
141.50%61.00K
---1.14M
---40.00K
---1.46M
---147.00K
-Change in payables and accrued expense
12.18%-6.73M
-23.29%3.98M
669.17%4.17M
-426.07%-1.75M
-108.80%-7.66M
92.50%5.18M
-129.58%-733.00K
-85.40%537.00K
2.55%-3.67M
26.09%2.69M
28.66%2.48M
-7.61%3.68M
-2.73%-3.77M
456.43%2.13M
-49.10%1.93M
--3.98M
---3.67M
---599.00K
--3.78M
-Change in other current liabilities
-102.52%-467.00K
-124.34%-2.25M
61.38%-4.08M
-129.95%-2.35M
779.71%18.56M
769.49%9.24M
-100.68%-10.57M
177.40%7.84M
53.57%-2.73M
90.84%-1.38M
-44.25%-5.27M
-294.08%-10.12M
-56.06%-5.88M
-298.68%-15.06M
15.17%-3.65M
---2.57M
---3.77M
---3.78M
---4.30M
Cash from non-recurring investing activities
Cash from operating activities
-83.71%-33.28M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
17.57%-24.01M
-9.59%-30.71M
14.41%-19.00M
-24.55%-33.13M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.20M
-6.67%-26.60M
-19.18%-25.67M
-27.52%-18.36M
---18.00M
---24.93M
---21.54M
---14.40M
Investing cash flow
Net cash from continuing investing activities
----
-102.55%-4.00K
-102.17%-13.00K
-45.58%197.00K
-100.00%0.00
-89.46%157.00K
-81.85%600.00K
-31.57%362.00K
242.44%589.00K
1266.97%1.49M
--3.31M
-29.18%529.00K
-59.14%172.00K
-62.54%109.00K
-100.00%0.00
--747.00K
--421.00K
--291.00K
--284.00K
Capital expenditures
----
----
----
-45.58%197.00K
-100.00%0.00
-89.46%157.00K
-81.85%600.00K
-31.57%362.00K
242.44%589.00K
1266.97%1.49M
--3.31M
-29.18%529.00K
-59.14%172.00K
-62.54%109.00K
-100.00%0.00
--747.00K
--421.00K
--291.00K
--284.00K
Net cash flow from disposal of fixed assets
----
-102.55%-4.00K
-102.17%-13.00K
-45.58%197.00K
-100.00%0.00
-89.46%157.00K
-81.85%600.00K
-31.57%362.00K
242.44%589.00K
1266.97%1.49M
--3.31M
-29.18%529.00K
-59.14%172.00K
-62.54%109.00K
-100.00%0.00
--747.00K
--421.00K
--291.00K
--284.00K
Net cash flow from investment products
154.55%29.13M
-57.43%13.67M
-99.74%149.00K
-174.20%-11.51M
-198.66%-53.40M
197.96%32.10M
151.20%58.33M
-54.05%15.51M
1512.32%54.12M
118.17%10.77M
123.07%23.22M
1.74%33.76M
93.75%-3.83M
-9.97%-59.30M
-214.10%-100.63M
--33.18M
---61.31M
---53.93M
---32.04M
Net cash flow from other investing activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---1.00K
----
Cash from non-current investing activities
Net cash flow from investing activities
154.55%29.13M
-57.21%13.67M
-99.72%162.00K
-177.28%-11.71M
-199.75%-53.40M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1436.94%53.53M
115.63%9.28M
119.79%19.91M
2.45%33.23M
93.51%-4.00M
-9.58%-59.41M
-211.34%-100.63M
--32.43M
---61.73M
---54.22M
---32.32M
Financing cash flow
Cash flow from continuous financing activities
-100.13%-46.00K
-99.81%112.00K
197.70%10.51M
118.10%135.00K
5155.99%34.58M
122606.38%57.67M
-3078.67%-10.75M
-388.03%-746.00K
-242.50%-684.00K
-89.91%47.00K
-38.18%361.00K
-99.85%259.00K
417.88%480.00K
-99.76%466.00K
-76.63%584.00K
--170.50M
---151.00K
--194.05M
--2.50M
Net cash flow from debt Issuance/repayment
----
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---11.00M
---750.00K
---750.00K
----
----
----
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
-100.46%-155.00K
-100.00%0.00
63825.00%10.20M
--0.00
36248.94%33.98M
--57.67M
---16.00K
--0.00
---94.00K
--0.00
--0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
--28.00K
---314.00K
--193.15M
---2.00M
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
----
--0.00
--4.50M
Proceeds from stock option exercised by employees
-100.00%0.00
--111.00K
--13.00K
6650.00%135.00K
826.79%519.00K
-100.00%0.00
-100.00%0.00
-99.23%2.00K
-78.46%56.00K
-93.75%47.00K
-75.83%211.00K
-51.95%259.00K
56.63%260.00K
-15.22%752.00K
--873.00K
--539.00K
--166.00K
--887.00K
--0.00
Net cash flow from other financing activities
29.76%109.00K
200.00%1.00K
12.93%297.00K
-100.00%0.00
-19.23%84.00K
---1.00K
75.33%263.00K
--2.00K
-52.73%104.00K
100.00%0.00
151.90%150.00K
-100.00%0.00
7433.33%220.00K
-1887.50%-286.00K
---289.00K
--169.93M
---3.00K
--16.00K
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.13%-46.00K
-99.81%112.00K
197.70%10.51M
118.10%135.00K
5155.99%34.58M
122606.38%57.67M
-3078.67%-10.75M
-388.03%-746.00K
-242.50%-684.00K
-89.91%47.00K
-38.18%361.00K
-99.85%259.00K
417.88%480.00K
-99.76%466.00K
-76.63%584.00K
--170.50M
---151.00K
--194.05M
--2.50M
Net cash flow
Beginning cash balance
-54.67%58.94M
-2.07%63.09M
58.96%76.56M
76.48%93.10M
293.65%130.03M
21.95%64.42M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-67.79%52.83M
-78.55%60.58M
-49.45%49.28M
-56.92%79.40M
148.48%164.02M
156.21%282.42M
--97.49M
--184.30M
--66.01M
--110.23M
Current period cash flow changes
88.61%-4.21M
-106.33%-4.15M
-182.79%-13.46M
-260.07%-16.55M
-287.26%-36.93M
431.40%65.61M
310.01%16.27M
-140.69%-4.59M
165.48%19.72M
76.60%-19.80M
93.46%-7.75M
-93.89%11.29M
65.31%-30.12M
-171.53%-84.62M
-167.77%-118.40M
--184.93M
---86.81M
--118.29M
---44.22M
Ending cash balance
-41.21%54.74M
-54.67%58.94M
-2.07%63.09M
58.96%76.56M
76.48%93.10M
293.65%130.03M
21.95%64.42M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-67.79%52.83M
-78.55%60.58M
-49.45%49.28M
-56.92%79.40M
148.48%164.02M
--282.42M
--97.49M
--184.30M
--66.01M
Free cash flow
-83.71%-33.28M
25.80%-17.93M
22.92%-24.13M
73.29%-5.17M
46.26%-18.12M
21.07%-24.17M
0.06%-31.31M
14.81%-19.36M
-25.95%-33.71M
-18.77%-30.62M
-70.63%-31.32M
-21.20%-22.72M
-5.57%-26.77M
-18.09%-25.78M
-25.05%-18.36M
---18.75M
---25.36M
---21.83M
---14.68M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
